Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Baxter International Inc

Healthcare US BAX

19.085USD
0.55(2.94%)

Last update at 2026-06-04T17:59:00Z

Day Range

18.9019.50
LowHigh

52 Week Range

15.7332.24
LowHigh

Fundamentals

  • Previous Close 18.54
  • Market Cap9545.51M
  • Volume2988171
  • P/E Ratio-
  • Dividend Yield2.76%
  • EBITDA2018.00M
  • Revenue TTM11244.00M
  • Revenue Per Share TTM21.92
  • Gross Profit TTM 4018.00M
  • Diluted EPS TTM-1.75

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -505.00000M -289.00000M 242.00M -2353.00000M 1477.00M
Minority interest 0.00000M -11.00000M -7.00000M 12.00M 11.00M
Net income -957.00000M -649.00000M 2656.00M -2421.00000M 1284.00M
Selling general administrative 2890.00M 2967.00M 3938.00M 3862.00M 2878.00M
Selling and marketing expenses - 1764.00M 985.00M 25.00M -11.00000M
Gross profit 3379.00M 3984.00M 4150.00M 5397.00M 5105.00M
Reconciled depreciation 981.00M 997.00M 1263.00M 1403.00M 890.00M
Ebit -215.00000M 119.00M 750.00M -549.00000M 779.00M
Ebitda 766.00M 1116.00M 1734.00M 854.00M 1669.00M
Depreciation and amortization 981.00M 997.00M 984.00M 1403.00M 890.00M
Non operating income net other - - - -15.00000M -41.00000M
Operating income -308.00000M 14.00M 707.00M -549.00000M 779.00M
Other operating expenses 11552.00M 10622.00M 9653.00M 14244.00M 11074.00M
Interest expense 290.00M 408.00M 508.00M 395.00M 192.00M
Tax provision 395.00M 37.00M -34.00000M 68.00M 182.00M
Interest income 52.00M 67.00M 70.00M 20.00M 192.00M
Net interest income -238.00000M -341.00000M -442.00000M -395.00000M -192.00000M
Extraordinary items -57.00000M -312.00000M 2482.00M - 0.00000M
Non recurring - - - 2812.00M -
Other items - - - - -
Income tax expense 395.00M 37.00M 61.00M 68.00M 182.00M
Total revenue 11244.00M 10636.00M 10360.00M 15113.00M 12784.00M
Total operating expenses 3687.00M 3970.00M 3443.00M 4528.00M 3395.00M
Cost of revenue 7865.00M 6652.00M 6210.00M 9716.00M 7679.00M
Total other income expense net -197.00000M -303.00000M -465.00000M -1804.00000M 698.00M
Discontinued operations - - - - -
Net income from continuing ops -900.00000M -326.00000M -69.00000M -2421.00000M 1295.00M
Net income applicable to common shares -957.00000M -649.00000M 2656.00M -2433.00000M 1284.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 20055.00M 25782.00M 28276.00M 28287.00M 33521.00M
Intangible assets 4369.00M 5223.00M 6079.00M 6793.00M 7792.00M
Earning assets - - - - -
Other current assets 740.00M 3313.00M 839.00M 399.00M 390.00M
Total liab 13953.00M 18758.00M 19808.00M 22392.00M 24400.00M
Total stockholder equity 6129.00M 6964.00M 8402.00M 5833.00M 9077.00M
Deferred long term liab - - - 119.00M 99.00M
Other current liab 1741.00M 2363.00M 2050.00M 1917.00M 2189.00M
Common stock 683.00M 683.00M 683.00M 683.00M 683.00M
Capital stock 683.00M 683.00M 683.00M 683.00M 683.00M
Retained earnings 13705.00M 14929.00M 16114.00M 14050.00M 17065.00M
Other liab - - - 1959.00M 2493.00M
Good will 4929.00M 5275.00M 6514.00M 6843.00M 9836.00M
Other assets 520.00M 3064.00M - 653.00M 835.00M
Cash 1966.00M 1764.00M 3194.00M 1718.00M 2951.00M
Cash and equivalents 1966.00M 1764.00M - 1718.00M 2951.00M
Total current liabilities 2970.00M 6511.00M 6503.00M 4745.00M 4236.00M
Current deferred revenue 141.00M 131.00M 148.00M 164.00M 162.00M
Net debt 8037.00M 11685.00M 11170.00M 15495.00M 15359.00M
Short term debt 84.00M 2832.00M 2796.00M 1525.00M 639.00M
Short long term debt 3.00M 2752.00M 2668.00M 1404.00M 511.00M
Short long term debt total 10003.00M 13449.00M 14364.00M 17213.00M 18310.00M
Other stockholder equity -4505.00000M -4638.00000M -4841.00000M -5067.00000M -5291.00000M
Property plant equipment 3186.00M 3176.00M - 5529.00M 5808.00M
Total current assets 6872.00M 8853.00M 9600.00M 8011.00M 8872.00M
Long term investments 103.00M 109.00M 194.00M 247.00M 154.00M
Net tangible assets - - - -7803.00000M 3796.00M
Short term investments - - - - -
Net receivables 1932.00M 1730.00M 2743.00M 2752.00M 2713.00M
Long term debt 9473.00M 10374.00M 11130.00M 15232.00M 17081.00M
Inventory 2232.00M 2046.00M 2824.00M 2718.00M 2453.00M
Accounts payable 999.00M 968.00M 1241.00M 1139.00M 1246.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - 62.00M 44.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3754.00000M -4010.00000M -3554.00000M -3833.00000M -3380.00000M
Additional paid in capital - - - - -
Common stock total equity - - - 683.00M 683.00M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 14050.00M 17065.00M
Treasury stock - - - -11389.00000M -11488.00000M
Accumulated amortization - - - - -
Non currrent assets other 596.00M 2942.00M 548.00M 584.00M 683.00M
Deferred long term asset charges - - - - -
Non current assets total 13183.00M 16929.00M 18676.00M 20276.00M 24649.00M
Capital lease obligations 304.00M 323.00M 566.00M 577.00M 650.00M
Long term debt total 9473.00M 10374.00M - 15232.00M 17149.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00000M -626.00000M 3187.00M -931.00000M -11200.00000M
Change to liabilities - - - -349.00000M 212.00M
Total cashflows from investing activities 2841.00M -626.00000M 3213.00M -931.00000M -11200.00000M
Net borrowings -3791.00000M -531.00000M -2935.00000M -899.00000M 9228.00M
Total cash from financing activities -4216.00000M -1081.00000M -3489.00000M -1438.00000M 8245.00M
Change to operating activities - - - -440.00000M -58.00000M
Net income -957.00000M -326.00000M 181.00M -2421.00000M 1295.00M
Change in cash -446.00000M -784.00000M 1476.00M -1234.00000M -780.00000M
Begin period cash flow 2414.00M 3198.00M 1722.00M 2956.00M 3736.00M
End period cash flow 1968.00M 2414.00M 3198.00M 1722.00M 2956.00M
Total cash from operating activities 845.00M 1019.00M 1726.00M 1211.00M 2222.00M
Issuance of capital stock - - - - -
Depreciation 981.00M 997.00M 984.00M 1403.00M 890.00M
Other cashflows from investing activities 3354.00M -200.00000M 3655.00M -252.00000M -10457.00000M
Dividends paid 348.00M 590.00M 586.00M -573.00000M -530.00000M
Change to inventory -119.00000M -201.00000M -128.00000M -361.00000M -37.00000M
Change to account receivables -132.00000M -35.00000M -38.00000M -146.00000M -170.00000M
Sale purchase of stock 30.00M 71.00M -95.00000M -32.00000M -600.00000M
Other cashflows from financing activities -107.00000M -31.00000M -63.00000M 121.00M -138.00000M
Change to netincome - - - 3085.00M -26.00000M
Capital expenditures 522.00M 460.00M 436.00M 679.00M 743.00M
Change receivables - - - -146.00000M -170.00000M
Cash flows other operating - - - - 58.00M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - -1158.00000M -733.00000M
Change in working capital -108.00000M -236.00000M 161.00M -1023.00000M -161.00000M
Stock based compensation 117.00M 114.00M 115.00M 154.00M 146.00M
Other non cash items 735.00M 732.00M 541.00M 3323.00M 198.00M
Free cash flow 323.00M 559.00M 1290.00M 532.00M 1479.00M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BAX
Baxter International Inc		 0.55 2.94% 19.09 - 9.73 0.85 1.56 1.54 22.66
ISRG
Intuitive Surgical Inc		 7.86 1.93% 415.15 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 - -% 201.48 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 3.96 4.03% 102.13 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 3.38 2.32% 148.99 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Baxter International Inc

One Baxter Parkway, Deerfield, IL, United States, 60015

Key Executives

Name Title Year Born
Mr. Jose E. Almeida Chairman, Pres & CEO 1962
Mr. James K. Saccaro Exec. VP & CFO 1973
Mr. Giuseppe Accogli Exec. VP & COO 1971
Mr. Andrew Frye Pres of Patient Support Systems, Global Surgical Solutions & Enterprise Connectivity 1965
Mr. Cristiano Franzi Sr. VP & Pres for EMEA 1963
Mr. Brian C. Stevens Sr. VP, Chief Accounting Officer & Controller 1975
Mr. Talvis P. Love Sr. VP & Chief Information Officer 1968
Ms. Clare Trachtman VP of Investor Relations NA
Mr. David S. Rosenbloom Sr. VP & Gen. Counsel NA
Ms. Stacey Eisen Sr. VP of Global Communications NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.